These results indicated that the diagnostic prediction model based on SIRT7, NTRK2, and CHI3L1 could effectively distinguish IDD patients from control population; therefore, these genes could serve as reliable biomarkers for specific diagnosis of IDD. This evidence concerns the gene CHI3L1 and intervertebral disk degenerative disorder.